High
1.0674
Open
1.040
VWAP
1.05
Vol
45.09K
Mkt Cap
61.02M
Low
1.030
Amount
47.45K
EV/EBITDA(TTM)
--
Total Shares
54.98M
EV
43.85M
EV/OCF(TTM)
--
P/S(TTM)
--
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight management and patients with type 2 diabetes, respectively. Its other pipeline product candidates include NPM-139, and OKV-119. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. It operates through two segments: Biopharm Division and Neuromodulation Division. The Company’s implant technology, which it refers as NanoPortal, utilizes a space-efficient design that allows a miniaturized implant to provide many months of therapeutic delivery of potent molecules.
Show More
2 Analyst Rating
288.35% Upside
Wall Street analysts forecast VANI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for VANI is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
288.35% Upside
Current: 1.030
Low
4.00
Averages
4.00
High
4.00
288.35% Upside
Current: 1.030
Low
4.00
Averages
4.00
High
4.00
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-04-16
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-04-16
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-04-04
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-04-04
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-03-26
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-03-26
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Reiterates
$4
2025-03-13
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$4
2025-03-13
Reiterates
Strong Buy
Reason
HC Wainwright & Co.
Yi Chen
Strong Buy
Initiates
$3
2024-11-07
Reason
HC Wainwright & Co.
Yi Chen
Price Target
$3
2024-11-07
Initiates
Strong Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Vivani Medical Inc (VANI.O) is -2.66, compared to its 5-year average forward P/E of -2.28. For a more detailed relative valuation and DCF analysis to assess Vivani Medical Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-2.28
Current PE
-2.66
Overvalued PE
-1.16
Undervalued PE
-3.41
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-1.14
Current EV/EBITDA
-2.75
Overvalued EV/EBITDA
1.14
Undervalued EV/EBITDA
-3.42
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
N/A
5Y Average PS
0.00
Current PS
0.00
Overvalued PS
0.00
Undervalued PS
0.00
Financials
Annual
Quarterly
FY2024Q4
N/A
Total Revenue
FY2024Q4
YoY :
+3.91%
-6.46M
Operating Profit
FY2024Q4
YoY :
+0.40%
-6.05M
Net Income after Tax
FY2024Q4
YoY :
-8.33%
-0.11
EPS - Diluted
FY2024Q4
YoY :
+44.60%
-6.11M
Free Cash Flow
FY2024Q4
N/A
Gross Profit Margin - %
FY2024Q4
N/A
FCF Margin - %
FY2024Q4
N/A
Net Margin - %
Trading Trends
Insider
Insiders areBuying! The selling amount has increased 23188.74% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
13
258.5K
USD
Months
3-6
2
5.0M
USD
Months
6-9
3
2.8K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders areBuying! The selling amount has increased 23188.74% over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
13
258.5K
USD
Months
3-6
2
5.0M
USD
Months
6-9
3
2.8K
USD
Months
0-12
0
0.0
USD
Months
VANI News & Events
Events Timeline
2025-04-15 (ET)
2025-04-15
08:38:58
Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs
2025-03-31 (ET)
2025-03-31
07:35:45
Vivani Medical to focus on developing NPM-115, NPM-139, emerging pipeline
2025-03-31
07:35:09
Vivani Medical announces anticipated upcoming milestones
Sign Up For More Events
Sign Up For More Events
News
1.0
04-16NewsfilterVivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company
4.0
04-16BenzingaHC Wainwright & Co. Reiterates Buy on Vivani Medical, Maintains $4 Price Target
7.5
04-15NewsfilterVivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity
Sign Up For More News
People Also Watch
FFIC
Flushing Financial Corp
12.450
USD
+0.81%
ATRO
Astronics Corp
22.640
USD
+2.68%
BCAL
Southern California Bancorp
14.070
USD
+1.88%
STOK
Stoke Therapeutics Inc
9.510
USD
+0.42%
PROK
ProKidney Corp
1.080
USD
+4.85%
GLRE
Greenlight Capital Re Ltd
13.230
USD
+0.68%
FMNB
Farmers National Banc Corp
13.220
USD
+1.07%
NNOX
Nano-X Imaging Ltd
4.990
USD
-3.11%
LINC
Lincoln Educational Services Corp
17.130
USD
-0.06%
LAAC
Lithium Americas (Argentina) Corp
2.740
USD
0.00%
FAQ
What is Vivani Medical Inc (VANI) stock price today?
The current price of VANI is 1.03 USD — it has decreased -1.9 % in the last trading day.
What is Vivani Medical Inc (VANI)'s business?
What is the price predicton of VANI Stock?
What is Vivani Medical Inc (VANI)'s revenue for the last quarter?
What is Vivani Medical Inc (VANI)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Vivani Medical Inc (VANI)'s fundamentals?
How many employees does Vivani Medical Inc (VANI). have?